One-way ANOVA revealed a significant downregulation of S100A4 in iPAH and CTEPH patients compared to AVS (iPAH: p = 0.008 and CTEPH: p = 0.004, respectively) (Figure 2D). Here, S100A4 is linked to chronic thromboembolic pulmonary hypertension.